HCA Healthcare Inc (HCA) Quote - XNYS | Morningstar

Skip to Content

Is it the right time to buy or sell?

Find out with Morningstar Premium

Is it the right time to buy or sell?

Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

HCA Turns In Weak Q1 and Reduces 2022 Outlook Primarily on Labor Challenges; Shares Fairly Valued

Senior Equity Analyst Julie Utterback

Julie Utterback, CFA Senior Equity Analyst

Analyst Note

| Julie Utterback, CFA | Apr 22, 2022

Narrow-moat HCA Healthcare turned in weaker-than-expected first-quarter results as labor cost inflation put pressure on the bottom line, and management has lowered its guidance for 2022 after only one quarter. However, considering cash flows generated since our last valuation update, we are not changing our $239 fair value estimate. Even with a midteens percentage drop after today's announcement, the shares still look about fairly valued.

Read Full Analysis

HCA Healthcare Inc's Company Profile

Business Description

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2020, the firm owned and operated 185 hospitals, 121 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Contact

One Park Plaza
Nashville, TN, 37203

T +1 615 344-9551

Mark.Kimbrough@hcahealthcare.com

www.hcahealthcare.com

Sector Healthcare

Industry Medical Care Facilities

Most Recent Earnings Mar 31, 2022

Fiscal Year End Dec 31, 2022

Stock Type Classic Growth

Employees 284,000

HCA Healthcare Inc's Related Articles & News

3 Sectors With the Biggest Fair Value Increases

As second-quarter earnings season winds down, we take a look at our analysts’ valuation changes across sectors.

The Winners of the New Definition of Infrastructure

Depending on which broader infrastructure projects take shape, numerous companies could see increased demand.

Stock Analyst Update

HCA Deal One of Largest in Its Recent History

The near $1.5 billion purchase of North Carolina's Mission Health gives the narrow-moat firm an immediately dominant presence in the area.

An Upgrade for Undervalued HCA Healthcare

We've assigned the largest hospital system in the U.S. a narrow economic moat and find shares attractive today.

Premium Article

10 Quality Stocks Now in Buying Range

These wide- and narrow-moat stocks shifted into 4-star territory this week.

Susan Dziubinski

Stock Strategist Industry Reports

Executive Orders Bring Uncertainty for Healthcare Exchanges

For now, we’re not changing our valuations or moat ratings for the affected companies.

Investing Specialists

Ultimate Stock-Pickers: Top 10 High-Conviction and New-Money Purchases

While overall activity for our top managers decreased again, our early read on the buying and selling activity during the period did uncover a few ideas worth considering.

The Morningstar Ultimate Stock-Pickers Team

Supreme Court's Affordable Care Act Decision Might Prove A Buying Opportunity

Morningstar analysts say that investors should not worry about the court's impending decision.

Fund Spy: Morningstar Medalist Edition

An Early Line on the Morningstar Domestic-Stock Fund Manager of the Year

These managers could be among those considered for the 2014 award.

9 Core Funds That Beat the Market

These actively managed offerings are led by experienced managers and have beaten their benchmarks during the past decade.

Behind Dodge & Cox Income's Gold Rating

Credit Insights

Investment Bankers Must Be on Spring Break

New issue supply fell well short of demand to put money to work last week.

Credit Insights

Treasury Bonds Take It on the Chin

Strong job growth sent Treasury rates upward, but corporate credit spreads held steady on a flood of new issues.

Quarter-End Insights

Our Outlook for the Credit Markets

The corporate bond market will probably struggle to return much above break-even in 2014.

Don't Pay Up for These Stocks

These no-moat stocks don't provide an appropriate margin of safety in today's market.

Quarter-End Insights

Credit Outlook: Sector Updates and Top Bond Picks

Get our sector-by-sector take on the bond market, plus our five best bond ideas.

Credit Insights

Plenty of Cheap Debt to Go Around

U.S. banks have repaired their balance sheets and have ample credit capacity available to provide commitment letters supporting M&A activity.

Quarter-End Insights

Credit Outlook: Sector Updates and Top Bond Picks

Get our sector-by-sector take on the bond market, plus our five best bond ideas.

Credit Insights

Corporations Take Advantage of Low Yields

Considering the uncertainty in future tax policy driven by the fiscal cliff negotiations, we suspect there will be one last push of new bond issues as corporations evaluate debt-funded special dividends.

Stock Strategist Industry Reports

Patient Trends Improving, but Reimbursement Outlook Remains Bleak for Health Service Providers

Greater accountability creates a new level of operating uncertainty.

Michael Waterhouse

Transparency is our policy. Learn how it impacts everything we do.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.